Company Profiles

driven by the PitchBook Platform

3Scan

Description

Developer of a robotic microscope technology designed to develop 3-D digital reconstruction of brain tissue. The company's robotic microscope Knife Edge Scanning Microscope (KESM) brings together elements of machine vision, automated serial sectioning, micro-machining and advanced optics, it slices the tissue samples very precisely, it's system then derives 10,000 slices from each tissue sample and then uses machine vision to generate a digital, 3-D spatial map which researchers can review and explore on a screen, providing scientists with a better view and more comprehensive data set from any given tissue sample.

PRIVATE

Status

11-50

Employees

Corporate

Latest Deal Type

$22.2M

Total Amount Raised

12

Investors

Description

Developer of a robotic microscope technology designed to develop 3-D digital reconstruction of brain tissue. The company's robotic microscope Knife Edge Scanning Microscope (KESM) brings together elements of machine vision, automated serial sectioning, micro-machining and advanced optics, it slices the tissue samples very precisely, it's system then derives 10,000 slices from each tissue sample and then uses machine vision to generate a digital, 3-D spatial map which researchers can review and explore on a screen, providing scientists with a better view and more comprehensive data set from any given tissue sample.

Website:

www.3scan.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

2122 Bryant Street San Francisco, CA 94110United States +1 (415) 851-5376
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore 3Scan's full profile, request a free trial.

3Scan Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

3Scan Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

3Scan Investors (12)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alchemist AcceleratorAccelerator/IncubatorMinority000 0000000 0000
Breakout LabsVenture CapitalMinority000 0000000 0000
Comet LabsVenture CapitalMinority000 0000000 0000
Data CollectiveVenture CapitalMinority000 0000000 0000
Dolby Family VenturesVenture CapitalMinority000 0000000 0000
Alchemist Accelerator Accelerator/Incubator
Breakout Labs Venture Capital
Comet Labs Venture Capital
Data Collective Venture Capital
Dolby Family Ventures Venture Capital

3Scan Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Todd HuffmanCo-Founder, Chief Executive Officer, President & Board Member
Megan KlimenCo-Founder and Chief Operating Officer
Matthew Goodman Ph.DChief Technology Officer & Co-Founder
Molly Maloof MDDirector, Clinical Strategy
Caroline MillerDirector, Histology
Todd Huffman Co-Founder, Chief Executive Officer, President & Board Member
Megan Klimen Co-Founder and Chief Operating Officer
Matthew Goodman Ph.D Chief Technology Officer & Co-Founder
Molly Maloof MD Director, Clinical Strategy
Caroline Miller Director, Histology

3Scan Board Members (4)

NameRepresentingRoleSinceContact
Info
Adam Goulburn Ph.DLux CapitalPartner000 0000
Joshua WolfeLux CapitalManaging Partner & Co-Founder000 0000
Matthew OckoData CollectiveCo-Founder and Co-Managing Partner000 0000
Todd Huffman3ScanCo-Founder, Chief Executive Officer, President & Board Member000 0000
Adam Goulburn Ph.D Partner Lux Capital
Joshua Wolfe Managing Partner & Co-Founder Lux Capital
Matthew Ocko Co-Founder and Co-Managing Partner Data Collective
Todd Huffman Co-Founder, Chief Executive Officer, President & Board Member 3Scan
Request full access to PitchBook